請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35374完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 周晉澄(Chin-Cheng Chou) | |
| dc.contributor.author | Hung-Jen Liao | en |
| dc.contributor.author | 廖鴻仁 | zh_TW |
| dc.date.accessioned | 2021-06-13T06:50:06Z | - |
| dc.date.available | 2005-08-01 | |
| dc.date.copyright | 2005-08-01 | |
| dc.date.issued | 2005 | |
| dc.date.submitted | 2005-07-28 | |
| dc.identifier.citation | 1.方秋霖。禽畜飼料添加肉骨粉之基本概念。中國畜牧雜誌。2000。31(9): 71-74。
2.行政院農業委員會。農業統計年報。1979-2001。行政院農業委員會，台北。 3.行政院農業委員會。2005。Website:http://www.coa.gov.tw/。 4.行政院農業委員會動植物防疫檢疫局。2005。Website:http://www.baphiq.gov.tw/。 5.行政院農業委員會動植物防疫檢疫局。化製場化製數量調查資料。2002。行政院農業委員會動植物防疫檢疫局，台北。 6.行政院農業委員會畜產試驗所。畜產要聞。畜產專訊第43期。2002。 7.行政院環境保護署。2005。Website:http://www.epa.gov.tw/main/index.asp。 8.李淑慧、張國慧。研習牛海綿狀腦病診斷技術。2001。行政院農業委員會所屬各機關出國報告。行政院農業委員會，台北。 9.呂振森譯。機率與統計-機率篇。2002。東華書局，台北。 10.吳中興，王豐政。病死豬化製廠處理技術。第二屆畜牧廢棄資源再生利用推廣研究成果研討會論文集。1998。83-96。 11.林享能。因應狂牛病對臺灣之威脅。國政評論。2001。科經(評); 090-039。 12.洪平。飼料原料要覽(含添加物)。1987。臺灣養羊雜誌社。台南。 13.財團法人臺灣動物科技研究所。2005。Website:http://www.atit.org.tw/annual/applied_biology.html 14.國立中興大學。加強畜牧政策經濟與制度之研究-斃死豬集運處理體系規劃及輔導策略之研究。2003。農委會補助研究期末報告書。 15.陳麗婷，李素菁，華傑。兩岸飼料產業現況與發展趨勢。2000。食品工業發展研究所。台北。 16.黃森源。我國養牛產業之現況與展望。畜產報導月刊。2001。17: 4-8。 17.程雋。應用機率論。1996。文笙書局，台北。 18.童榮信。淺談乳牛營養中過瘤胃蛋白的幾個問題。中國畜牧雜誌。1995。9： 113-117。 19.雲林縣家畜疾病防治所。雲林縣化製場管理與執行報告。2005。雲林縣家畜疾病防治所，雲林。 20.莊金谷。乳牛產業結構調整措施執行成果。畜牧半月刊。2003。70: 87-93。 21.經濟部國貿局。進出口貿易統計年報。1979-2004。經濟部國貿局，台北。 22.劉振軒。牛海綿狀腦病。乙類動物傳染病之簡介。1999。財團法人動物科技研究所，苗栗。 23.臺灣省政府農林廳。臺灣畜牧獸醫事業養牛編。1985。臺灣省政府農林廳，南投。 24.鄭博豪、金悅祖、羅玲玲、楊天樹。狂牛症省思與市售飼料中肉骨粉含量調查分析。中畜會誌。2003。32(4): 206。 25.鄭瑞基。本省乳牛之淘汰原因。雜糧與畜產。1996。278: 40-41。 26.雷鵬魁。動物屍體處理之規劃與分析。行政院農業委員會動植物防疫檢疫局91年度科技研究計畫研究報告。2002。 27.Anderson RM, Donnelly CA, Ferguson NM, Woolhouse ME, Watt CJ, Udy HJ, MaWhinney S, Dunstan SP, Southwood TR, Wilesmith JW. Ryan JB. Hoinville LJ, Hillerton JE, Austin AR, Wells GA. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996; 382: 779-788. 28.Braun U, Amrein E, EstermannU, Pusterla N, Schonmann M, SchweizerT, Ehrensperger F, Vandevelde M, Kihm U. Reliability of a diagnosis of BSE made on the basis of clinical signs. Vet Rec 1999; 145: 198-200. 29.Brown P, Gibbs CJ, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-529. 30.Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A ,McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 1997; 389: 498- 501. 31.Cashman NT, Loertscher R, Nalbantoglu J, Shaw I, Kascsak RJ, Bolton DC, Bendheim PE. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 1990; 61: 185-192. 32.Chesebro B. Prion protein and the transmissible spongiform encephalopathy diseases. Neuron 1999; 24: 503-506. 33.Cohen JT, Duggar K, Gray GM, Kreindel S. Evaluation of the potential for bovine spongiform encephalopathy in the United States. 2001. Harvard Center for Risk Analysis, Harvard School of Public Health, Boston. 34.Cohen FE, Pan KM, Huang Z, Baldwin M, Fletterick RJ, Prusiner SB. Structural clues to prion replication. Science 1994; 264: 530-531. 35.Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 1996; 383: 685-690. 36.Danish Institute for Food and Veterinary Research. Estimation of the relative BSE infectivity (risk) of meat and bone meal (MBM), bone meal(BM), greaves and tallow. 2002. Danish Ministry of Food, Agriculture and Fisheries, Denmark. Website:http://www.dfvf.dk/. 37.Dawson MG, Wells GAH, Parker BNJ, Scott AC. Primary parenteral transmission of bovine spongiform encephalopathy to the pig. Vet Rec 1990; 127: 338. 38.Diringer H, Roehmel J, Beekes M. Effect of repeated oral infection of hamsters with scrapie. J Gen Virol 1998; 79: 609-612. 39.Dunn KJ. Guidelines for the evaluation of veterinary services. Rev Sci Tech Off Int Epiz 1993; 12: 1291-1313. 40.European Commission. No evidence for BSE transmission through milk. 1999. Website:http://europa.eu.int/comm/dgs/health_consumer/library/press/press28_en.html. 41.European Economic Community（EEC）. Commission decision 96/449/EC of 18 July 1996 on the approval of alternative heat treatment systems for processing animal waste with a view to the inactivation of spongiform encephalopathy agents. Off J EC 1996; 184: 43-46. 42.Fishbein L. Transmissible spongiform encephalopathy, hypotheses and food safety: an overview. Sci Tot Env 1998; 217: 71-82. 43.Gale P, Stanfield G. Towards a quantitative risk assessment for BSE in sewage sludge. J App Mic 2001; 91: 563-569. 44.Glatzel M, Aguzzi A. PrPC expression in the peripheral nervous system is a determinant of prion neuroinvasion. J Gen Virol 2000; 81: 2813-2821. 45.Griffith JS. Self-replication and scrapie. Nature 1967; 215: 1043-1044. 46.Hadlow WJ, Race RE, Kennedy RC. Experimental infection of sheep and goats with transmissible mink spongiform encepathlopathy virus. Can J Vet Res 1987; 51: 135-144. 47.Hartsough GR, Burger D. Encephalopathy of the mink. J Inf Dis 1965; 115:387-392. 48.Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448-450. 49.Jackson GS, Hosszu LLP, Power A, Hill AF, Kenney J, Saibil H, Craven CJ, Waltho JP, Clarke AR, Collinge J. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 1999; 283: 1935-1937. 50.John AF, Peterson HH. Risk and implications of bovine spongiform encephalopathy for the United States: insights from other countries. Food Policy 2004; 29: 45-60. 51.Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ. Scrapie prion proteins are synthesized in neurons. Am J Pathol 1986; 122: 1-5. 52.Matthews D, Cooke BC. The potential for transmissible spongiform encephalopathy in non-ruminant livestock and fish. Rev Sci Tech 2003; 22: 283-296. 53.McCrea D. Risk communication of the transmissible spongiform encephalopathies. Rev Sci Tech Off Int Epiz 2003; 22: 251-257. 54.Miller L, McElvaine MD, McDowell RM, Ahl AS. Developing a quantitative risk assessment process. Rev Sci Tech Off Int Epiz 1993; 12: 1153-1164. 55.Morley RS. A model for the assessment of the animal disease risks associated with the importation of animals and animal products. Rev Sci Tech Off Int Epiz 1993; 12: 1055-1092. 56.Morley RS, Chen S, Rheault N. Assessment of the risk factors related to bovine spongiform encephalopathy. Rev sci tech off int Epiz 2003; 22: 157-178. 57.Murray N. Handbook on import risk analysis for animals and animal products, volume1 qualitative risk assessment. 2004a. OIE, French. 58.Murray N. Handbook on import risk analysis for animals and animal products, volume2 quantitative risk assessment. 2004b. OIE, French. 59.Murray N. Workshop on quantitative risk assessment. @risk 4.5 professional training. 2004. Animal Health Risk Analysis Group, Science Branch, Canadian Food Inspection Agency, Canada. 60.Oesch B, Westaway D, Walchli M, McKinley MP, Kent SB, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, Prusiner SB, Weissmann C. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985;40: 735-746. 61.Ozawa Y. Risk management of transmissible spongiform encephalopathies in asia. Rev sci tech Off int Epiz 2003; 22: 237-249. 62.Paisley LG, Hostrup-Pedersen J. A quantitative assessment of the risk of transmission of bovine spongiform encephalopathy by tallow-based calf milk-replacer. Prev Vet Med 2004; 63: 135-149. 63.Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993; 90: 10962-10966. 64.Pearson GR, Wyatt JM, Gruffydd-Jones TJ, Hope J, Chong A, Higgins RJ, Scott AC, Wells GAH. Feline spongiform encephalopathy: fibril and PrP studies. Vet Rec 1992; 131: 307-310. 65.Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-144. 66.Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95: 13363-13383. 67.Prusiner SB. Scrapie prions. Annu Rev Microbio 1989; 43: 345-374. 68.Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG. Scrapie prions aggregate to form amyloid-like birefrigent rods. Cell 1983; 35: 349-358. 69.Schreuder BBC, Wilesmith JW, Ryan JBM, Straub OC. Risk of BSE from the import of cattle from the United Kingdom into countries of the European Union. Vet Rec 1997; 141: 187-190. 70.Scientific Steering Committee (SSC). Opinion on BSE risk adopted by Scientific Steering Committee at its plenary meeting 26-27 March 1998, following a public consultation on the preliminary opinion adopted on 19-20 February 1998. 1998. EC, SSC, Brussels. Website:http://europa.eu.int/comm/food/fs/sc/ssc/out13_en.html. 71.Scientific Steering Committee (SSC). Opinion on the safety of gelatine, adopted at the Scientific Steering Committee at its plenary meeting of 26-27 March 1998, following a public consultation on the preliminary opinion adopted on 19-20 February 1998 (Version updated on 3.04.98). 1998. EC, SSC, Brussels. Website:http://europa.eu.int/comm/food/fs/sc/ssc/out09_en.pdf. 72.Scientific Steering Committee (SSC). Opinion of the Scientific Steering Committee on the human exposure risk (HER) via food with respect to BSE, adopted on 10 December 1999. 1999. EC, SSC, Brussels. Website:http://europa.eu.int/comm/food/fs/sc/ssc/out67_en.pdf. 73.Scientific Steering Committee (SSC). Scientific report on the risks of non conventional transmissible agents, conventional infectious agents or other hazards such as toxic substances entering the human food or animal feed chains via raw material from fallen stock and dead animals (including also: ruminants, pigs, poultry, fish, wild/exotic/zoo animals, fur animals, cats, laboratory animals and fish) or via condemned materials. Submitted to the Scientific Steering Committee at its meeting of 24-25 June 1999. 1999. EC, SSC, Brussels. Website:http://www.europa.eu.int/comm/food/fs/sc/ssc/out58_en.pdf. 74.Scientific Steering Committee (SSC). The risk born by recycling animal by-products as feed with regard to propagating TSE’s in non-ruminant farmed animals, prepared by a working group for the Scientific Steering Committee as an input in the elaboration of the opinion on the same subject adopted on 16-17 September 1999. 1999. EC, SSC, Brussels. Website:http://europa.eu.int/comm/food/fs/sc/ssc/out59_en.html. 75.Scientific Steering Committee (SSC). Final opinion of the Scientific Steering Committee on the geographical risk of bovine spongiform encephalopathy (GBR), adopted on 6/July/2000. 2000. EC, SSC, Brussels. Website:http://europa.eu.int/comm/food/fs/sc/ssc/out113_en.pdf. 76.Scientific Steering Committee (SSC). Opinion of oral exposure of humans to the BSE agent: infective dose and species barrier, adopted by Scientific Steering Committee at its meeting of 13-14 April 2000, following a public consultation via Internet between 6 and 27 March 2000. 2000. EC, SSC, Brussels. Website:http://europa.eu.int/comm/food/fs/sc/ssc/out79_en.pdf. 77.Scientific Steering Committee (SSC). Opinion of the safety of ruminant blood with respect to TSE risks, adopted by the Scientific Steering Committee at its meeting of 13-14 April 2000. 2000. EC, SSC, Brussels. Website:http://www.europa.eu.int/comm/food/fs/sc/ssc/out74_en.pdf. 78.Scientific Steering Committee (SSC). The safety of bovine embryos, amendment to the SSC opinion of 18-19 March 1999 on the possible vertical transmission of bovine spongiform encephalopathy (BSE), adopted by the Scientific Steering Committee at its meeting of 16 May 2002. 2002. EC, SSC, Brussels. Website:http://www.europa.eu.int/comm/food/fs/sc/ssc/out263_en.pdf. 79.Scientific Steering Committee (SSC). Update of the opinion on TSE infectivity distribution in ruminant tissues (Initially adopted by the Scientific Steering Committee at its meeting of 10-11 January 2002 and amended at its meeting of 7-8 November 2002) following the submission of (1) a risk assessment by the German Federal Ministry of Consumer Protection, food and Agriculture and (2) new scientific evidence regarding BSE infectivity distribution in tonsils. 2002. EC, SSC, Brussels. Website:http://europa.eu.int/comm/food/fs/sc/ssc/out296_en.pdf. 80.Scientific Steering Committee (SSC). The assessment of the geographical risk of bovine spongiform encephalopathy carried out world by the European Commission’s Scientific Steering Committee. 2003. EC, SSC, Brussels. Website:http://www.europa.eu.int/comm/food/fs/sc/ssc/out363_en.pdf. 81.Sellier P. Protein nutrition for ruminants in European countries, in the light of animal feeding regulations linked to bovine spongiform encephalopathy. Rev sci tech off int Epiz 2003; 22(1): 259-269. 82.Sigurdson CJ, Miller MW. Other animal prion disease. Brit Med Bull 2003; 66: 199-212. 83.Sugiura K. Risk of introduction of BSE into Japan by the historical imporation of cattle from the United Kingdom and Germany. Prev Vet Med 2004; 64: 191-200. 84.Taylor DM. Current perspectives on bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Clin Microbiol Infect 2002; 8: 332-339. 85.Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 2000; 159: 10-17. 86.Taylor DM, Woodgate SL. Bovine spongiform encephalopathy: the causal role of ruminant-derived protein in cattle diets. Rev Sci Tech 1997; 16(1): 187-198. 87.Taylor DM, Woodgates SL. Rendering practices and inactivation of transmissible spongiform encephalopathy agents. Rev sci tech Off Int Epiz. 2003; 22(1): 297-310. 88.Taylor DM, Woodgate SL, Atkinson MJ. Inactivation of the bovine spongiform encephalopathy agent by rendering procedures. Vet Rec 1995; 137(24): 605-610. 89.Taylor DM, Woodgate SL, Fleetwood AJ, Cawthorne RJ. Effect of rendering procedures on the scrapie agent. Vet Rec 1997; 141: 643-649. 90.United Kingdom. BSE Inquiry. 2000. Website:http://www.bseinquiry.gov.uk/report/html. 91.United Kingdom. Department of Health. 2005. Website:http:// http://www.dh.gov.uk/Home/fs/en. 92.Vose DJ. Quantitative risk analysis: a guide to Monte Carlo simulation. 1996. Wiley, New York. 93.Vose DJ. The application of quantitative risk assessment to microbial food safety. J Food Prot 1998; 61: 640-648. 94.Vose DJ. Risk analysis: a quantitative guide, 2nd ed 2000. Wiley, Chichester. 95.Wahlstrom H, Elvander M, Engvall A, Vagsholm I. Risk of introduction of BSE into Sweden by import of cattle from the United Kingdom. Prev Vet Med 2002; 54: 131-139. 96.Wells GA, Dawson M, Hawkins SAC, Green RB, Dexter I, Francis ME, Simmons MM, Austin AR, Horigan MW. Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy. Vet Rec 1994; 135: 40-41. 97.Wells GA, Hawkins SAC, Green RB, Austin AR, Dexter I, Dawson M. Limited detection of sternal bone marrow infectivity in the clinical phase of experimental bovine spongiform encephalopathy (BSE). Vet Rec 1999; 144: 292-294. 98.Wells GA, Hawkins SAC, Green RB, Austin AR, Dexter I, Spencer YI, Chaplin MJ, Stack MJ, Dawson M. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec 1998; 142: 103-106. 99.Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M, Bradley R. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987; 121: 419-420. 100.Wilesmith JW, Wells GA. A cohort study to examine maternally-associated risk factors for bovine spongiform encephalopathy. Vet Rec 1997;141: 239-243. 101.Wilesmith JW. Preliminary epidemiological analyses of the first 16 cases of BSE born after July 31, 1996, in Great Britain. Vet Rec 2002; 151: 451-452. 102.Wilesmith JW, Hoinville LJ, Ryan JBM, Sayers AR. Bovine spongiform encephalopathy: aspects of the clinical picture and analyses of possible changes 1986-1990. Vet Rec 1992; 130: 197-201. 103.Wilesmith JW, Ryan JBM, Hueston WD. Bovine spongiform encephalopathy: case-control studies of calf feeding practices and meat-and-bone meal inclusion in proprietary concentrates. Res Vet Sci 1992; 52: 325-331. 104.Wilesmith JW, Ryan JBM, Hueston WD, Hoinville LJ. Bovine spongiform encephalopathy: epidemiological features 1985 to 1990. Vet Rec 1992;130: 90-94. 105.Wilesmith JW, Wells GA. Scrapie, Creutzfeldt-Jakob disease and other spongiform encephalopathies. Microbiology and immunology. Ed Cheesebro BW. Berlin Springer Verlag 1991; 172: 21-38. 106.Wilesmith JW, Wells GA, Cranwell MP, Ryan JBM. Bovine spongiform encephalopathy: epidemiological studies. Vet Rec 1988; 123: 638-644. 107.Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, AlberobitchA, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921- 925. 108.Williams ES, Miller MW. Transmissible spongiform encephalopatyies in non-domestic animals: origin, transmission and risk factors. Rev Sci Tech 2003; 22: 145-156. 109.Wilson DW, Banks DJD. The application of risk assessment in animal quarantine in Australia. Rev Sci Tech Off Int Epiz 1993; 12: 1121-1133. 110.World Health Organization. WHO infection control guidelines for transmissible spongiform encephalopathies. Report of a WHO consultation, Geneva, Switzerland, 23-26 March 1999. (WHO/CDS/CSR/APH/2000.3). Website:http://www.who.int/emc 111.World Organisation for Animal Health (OIE). 2005. Paris. Website:http://www.oie.int/eng /en_index.htm. 112.World Organisation for Animal Health (OIE). Bovine spongiform encephalopathy. Terrestrial animal health code 2004; chapter 3.2.13. Paris. 113.Wrathall AE. Risks of transmitting scrapie and bovine spongiform encephalopathy by semen and embryos. Rev Sci Tech 1997; 16: 240-264. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35374 | - |
| dc.description.abstract | 本研究針對臺灣自牛海綿狀腦病（bovine spongiform encephalopathy, BSE）疫區國進口活牛及肉骨粉數量，評估臺灣養牛產業環境至少發生一起病例之機率，依據病原特性與國內牛隻養殖、屠宰、化製處理、飼料場作業情形，建構BSE風險評估樹狀圖，收集風險因子資料及推估風險數值。風險評估樹狀圖中共包含五項程序及四項風險路徑，運用@RISK軟體，將風險路徑以Latin Hypercube抽樣方法重複測定10,000次，依此估算最終風險數值。結果顯示，臺灣於1979年至2004年自疫區國進口牛隻及肉骨粉，造成臺灣地區至少發生一起BSE病例之最大風險為4.84E-4，評估結果其風險不可忽略，另依英國發生率遞減情形估算，2004年該風險值已降至百萬分之一以下，目前已達可接受範圍。牛隻主要由美國、加拿大及日本進口，其殘體製成肉骨粉餵飼牛隻之總風險值為5.08E-12，另為估算自疫區進口牛隻造成垂直傳播病例之風險，本研究模擬試算結果風險值為7.79E-14~1.09E-8。由敏感性分析可知，遭病原污染之肉骨粉作為牛隻飼料之機率與本研究推估之最終風險值相關性最大，因此，持續注意國際疫情，堅持反芻獸餵飼動物性飼料禁令，為重要疾病風險管制點。 | zh_TW |
| dc.description.abstract | The study evaluated the probability of bovine spongiform encephalopathy (BSE) invasion into cattle breeding circumstances in Taiwan by importing cattle and meat and bone meal (MBM) from infected country. According to pathogen characteristic, cattle farming, slaughter, rendering and feeding circumstances, the BSE risk assessment scenario tree was constructed, information of risk factors were collected and risk values were evaluated. The BSE risk assessment scenario tree included 5 sections and 4 pathways. The final risk value was simulated with 10,000 times of Latin Hypercube simulations by @RISK software. The results revealed the maximum risk of producing at least one case of BSE in Taiwan was 4.84E-4 depending on importing cattle and MBM during 1979 to 2004. Comparing with the decreasing incidence of United Kingdom, the risk value is descending less than one of a million in 2005 and is acceptable now than before. The total risk of importing cattle from United States, Canada and Japan was 5.08E-12 in consideration of infected cattle rendering and producing MBM to feed cattle. For the purpose of evaluating maternal transmission, the simulation results are between 7.79E-14~1.09E-8. In view of the sensitivity analysis, the final risk value was most correlated by the rate of contaminated MBM to feed cattle. Consequently, noticing the BSE epidemic in the world and insisting ruminate feed ban is the most important risk control point. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T06:50:06Z (GMT). No. of bitstreams: 1 ntu-94-R90629032-1.pdf: 1130076 bytes, checksum: 8c3612db63a69b1b88760c2295fb95e5 (MD5) Previous issue date: 2005 | en |
| dc.description.tableofcontents | 中文摘要 i
英文摘要 ii 致謝 iii 目錄 iv 表次 vi 圖次 viii 附錄 ix 第一章 序言 1 第二章 文獻探討 2 2-1 牛海綿狀腦病 2 2-2 風險分析 7 2-3 世界動物衛生組織標準 9 2-4 牛海綿狀腦病風險評估 10 2-5 相關產業 15 2-6 論文研究目的 18 第三章 材料與方法 20 3-1 台灣牛海綿狀腦病可能發生來源 20 3-2 建立臺灣牛海綿狀腦病風險評估模式 25 3-3 本研究應用之機率分佈 29 3-4 臺灣牛海綿狀腦病風險評估 31 3-5 垂直傳播風險評估 46 3-6 模擬試算方法 48 第四章 結果 49 4-1 模擬試算結果 49 4-2 敏感性分析結果 54 第五章 討論 56 5-1 臺灣牛海綿狀腦病風險評估結果討論 56 5-2 臺灣牛海綿狀腦病風險模式限制 60 第六章 結論與建議 62 第七章 參考文獻 63 | |
| dc.language.iso | zh-TW | |
| dc.subject | 風險評估 | zh_TW |
| dc.subject | 風險分析 | zh_TW |
| dc.subject | 牛海綿狀腦病 | zh_TW |
| dc.subject | bovine spongiform encephalopathy | en |
| dc.subject | risk analysis | en |
| dc.subject | risk assessment | en |
| dc.subject | BSE | en |
| dc.title | 臺灣牛海綿狀腦病量化風險評估 | zh_TW |
| dc.title | A Quantitative Risk Assessment for Bovine Spongiform Encephalopathy in Taiwan | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 王泛熒,蔡向榮,楊平政,李維誠 | |
| dc.subject.keyword | 牛海綿狀腦病,風險評估,風險分析, | zh_TW |
| dc.subject.keyword | bovine spongiform encephalopathy,BSE,risk assessment,risk analysis, | en |
| dc.relation.page | 83 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2005-07-28 | |
| dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
| dc.contributor.author-dept | 獸醫學研究所 | zh_TW |
| 顯示於系所單位： | 獸醫學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-94-1.pdf 未授權公開取用 | 1.1 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。